| # | Drug | Count |
|---|---|---|
| 0 | NATALIZUMAB | 220 |
| 1 | DIMETHYL FUMARATE | 175 |
| 2 | INTERFERON BETA-1A | 163 |
| 3 | FINGOLIMOD HCL | 101 |
| 4 | ERGOCALCIFEROL | 99 |
| 5 | TERIFLUNOMIDE | 96 |
| 6 | OFATUMUMAB | 94 |
| 7 | GABAPENTIN | 90 |
| 8 | BACLOFEN | 81 |
| 9 | ACETAMINOPHEN | 73 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LITHIUM CARBONICUM | 1 | 0.0106 |
| 1 | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | 1 | 0.0040 |
| 2 | ALEMTUZUMAB | 73 | 0.0038 |
| 3 | ERGOCALCIFEROL | 99 | 0.0033 |
| 4 | BUTORPHANOL TARTRATE | 1 | 0.0030 |
| 5 | DIMENHYDRINATE | 31 | 0.0029 |
| 6 | OFATUMUMAB | 94 | 0.0028 |
| 7 | LEVOLEUCOVORIN | 10 | 0.0026 |
| 8 | 12%AZELAIC ACID | 2 | 0.0024 |
| 9 | DIROXIMEL FUMARATE | 27 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 220 |
| 1 | Interferon beta [EPC] | 177 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 166 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 111 |
| 4 | Provitamin D2 Compound [EPC] | 99 |
| 5 | Pyrimidine Synthesis Inhibitor [EPC] | 96 |
| 6 | Benzodiazepine [EPC] | 82 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 81 |
| 8 | Corticosteroid [EPC] | 77 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 73 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 73 | 0.0038 |
| 1 | Provitamin D2 Compound [EPC] | 99 | 0.0033 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | Integrin Receptor Antagonist [EPC] | 220 | 0.0025 |
| 4 | Pyrimidine Synthesis Inhibitor [EPC] | 96 | 0.0021 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 18 | 0.0013 |
| 7 | Interferon beta [EPC] | 177 | 0.0009 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 81 | 0.0009 |
| 9 | Potassium Channel Blocker [EPC] | 55 | 0.0008 |